Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study
Journal
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Journal Volume
30
Journal Issue
11
Pages
2289
Date Issued
2019-11
Author(s)
Chang, C-K
Shih, C-W
Chen, K-Y
Abstract
This study investigated the alterations of mineral metabolism in patients with Graves' disease (GD) who achieved euthyroidism. They had higher fibroblast growth factor 23 (FGF23) and phosphorus as compared with healthy subjects. Serum FGF23 was negatively correlated with serum phosphorus. These indicated abnormal mineral metabolism even after 1.6 years of euthyroid status.
Subjects
Fibroblast growth factor 23; Graves’ disease; Osteoporosis; Phosphorus
Publisher
SPRINGER LONDON LTD
Type
journal article